Second time lucky for pharma buy-out?
Ten days after it sold off its Australian manufacturing plant, Mayne has dropped the hammer on another bid to buy it out for more than $600 million.
To see the whole article, log in or create an account.
Ten days after it sold off its Australian manufacturing plant, Mayne has dropped the hammer on another bid to buy it out for more than $600 million.
To see the whole article, log in or create an account.